Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MAIA Biotechnology, Inc.MAIA · Entity 6919 | Director | September 30, 2026 | October 03, 2026 |
| TransUnionTRU · Entity 2287 | President, US Markets | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MAIA Biotechnology, Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.18 · Expires 2036-09-30 | Direct | 32,774 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 32,774 · Balance 32,774 F1: The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
TransUnion
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 79,888 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Sale · Disposed 1,000 · Balance 79,888 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 20, 2019 Filed Dec 24, 2019 01:46 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 13,661 | $85.54 | $1,168,561.94 |
DisclosureSEC source: 0001776865-19-000009 · wf-form4_157715197994199.xml · nonDerivative · entry 2 CHAOUKI STEVEN M · CIK 0001776865 · EVP - US Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,012 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.19 to $86.38, inclusive. The reporting person undertakes to provide to TransUnion, any security holder of TransUnion, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 20, 2019 Filed Dec 24, 2019 01:46 UTC | TransUnion TRU · Entity 2287 | Exercise / conversionCommon Stock | 13,661 | $8.57 | $117,074.77 |
DisclosureSEC source: 0001776865-19-000009 · wf-form4_157715197994199.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · EVP - US Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 22, 2019 Filed Nov 25, 2019 23:15 UTC | TransUnion TRU · Entity 2287 | Exercise / conversionStock Options (right to buy) · Derivative | 13,662 | $8.57 Strike: $8.57 | $117,083.34 |
DisclosureSEC source: 0001776865-19-000007 · wf-form4_157472369458074.xml · derivative · entry 3 CHAOUKI STEVEN M · CIK 0001776865 · EVP - US Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,661 Underlying: Common Stock · 13,662 shares Expires 2023-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: Represents an initial grant of 53,985 stock options, 40% of which vest upon the attainment of time-based vesting criteria and 60% of which vest upon the attainment of both time-based and performance-based vesting criteria. The performance-based vesting criteria was satisfied on February 22, 2017, and all options now follow the time-based vesting criteria as follows: 20% on the first anniversary of the date of grant and 5% on the last day of each subsequent full calendar quarter. Read SEC document |
| November 22, 2019 Filed Nov 25, 2019 23:15 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 13,662 | $84.24 | $1,150,886.88 |
DisclosureSEC source: 0001776865-19-000007 · wf-form4_157472369458074.xml · nonDerivative · entry 2 CHAOUKI STEVEN M · CIK 0001776865 · EVP - US Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,012 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $83.61 to $85.31, inclusive. The reporting person undertakes to provide to TransUnion, any security holder of TransUnion, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 22, 2019 Filed Nov 25, 2019 23:15 UTC | TransUnion TRU · Entity 2287 | Exercise / conversionCommon Stock | 13,662 | $8.57 | $117,083.34 |
DisclosureSEC source: 0001776865-19-000007 · wf-form4_157472369458074.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · EVP - US Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:05 UTC | TransUnion TRU · Entity 2287 | Exercise / conversionStock Options (right to buy) · Derivative | 13,662 | $8.57 Strike: $8.57 | $117,083.34 |
DisclosureSEC source: 0001776865-19-000004 · wf-form4_157239383964635.xml · derivative · entry 3 CHAOUKI STEVEN M · CIK 0001776865 · EVP - US Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,323 Underlying: Common Stock · 13,662 shares Expires 2023-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: Represents an initial grant of 53,985 stock options, 40% of which vest upon the attainment of time-based vesting criteria and 60% of which vest upon the attainment of both time-based and performance-based vesting criteria. The performance-based vesting criteria was satisfied on February 22, 2017, and all options now follow the time-based vesting criteria as follows: 20% on the first anniversary of the date of grant and 5% on the last day of each subsequent full calendar quarter. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:05 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 13,662 | $83.02 | $1,134,219.24 |
DisclosureSEC source: 0001776865-19-000004 · wf-form4_157239383964635.xml · nonDerivative · entry 2 CHAOUKI STEVEN M · CIK 0001776865 · EVP - US Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,012 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.545 to $83.86, inclusive. The reporting person undertakes to provide to TransUnion, any security holder of TransUnion, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:05 UTC | TransUnion TRU · Entity 2287 | Exercise / conversionCommon Stock | 13,662 | $8.57 | $117,083.34 |
DisclosureSEC source: 0001776865-19-000004 · wf-form4_157239383964635.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · EVP - US Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.